FITC Anti-Human CD47 Antibody[CC2C6D4]

FITC Anti-Human CD47 Antibody[CC2C6D4]

The FITC Anti-Human CD47 Antibody[CC2C6D4] is a monoclonal antibody that is designed to specifically target and bind to the CD47 protein found on the surface of human cells. This antibody is conjugated with fluorescein isothiocyanate (FITC), which allows for easy detection and visualization of the CD47 protein in various applications such as flow cytometry and immunofluorescence microscopy. The CC2C6D4 clone of this antibody has been extensively tested and validated for its specificity and sensitivity in detecting human CD47.

CD47 is a transmembrane protein that plays a crucial role in regulating various cellular processes such as cell adhesion, migration, and phagocytosis. It is also known to be overexpressed in various types of cancer cells, making it an attractive target for cancer immunotherapy. The FITC Anti-Human CD47 Antibody[CC2C6D4] can be used to study the expression and function of CD47 in normal and cancer cells, as well as to develop novel therapeutic strategies targeting CD47.

This antibody is supplied as a liquid in phosphate-buffered saline (PBS) with 0.1% sodium azide as a preservative. It is recommended to store the antibody at 4°C and avoid repeated freeze-thaw cycles. The FITC Anti-Human CD47 Antibody[CC2C6D4] is a valuable tool for researchers studying the role of CD47 in various biological processes and diseases, and it has the potential to contribute to the development of new cancer therapies.